T lymphocytes are mainly divided into two subsets, CD4+ T cells and CD8+ T cells (96), and the specific immune responses they mediate are an important part of anti-tumor cellular immunity and are closely related to tumor development and prognosis (97). The gene discussed is CD4; the disease is neoplasm.